From the Leeunhowoek report........Thanks to Gowie,,,,
LAG-3 is an increasingly important immuno-oncology target, which is dominated by Prima BioMed - See more at: http://www.b-tv.com/undervalued-companies-biotech-subsectors/#sthash.s3t2Ymyg.dpuf
Seems like Leeunhowoek are still keen on Prima, also from one of Gowies earlier posts, Edison are
waiting on EOY report to upgrade their analysis......
From the Leeunhowoek report........Thanks to Gowie,,,, LAG-3 is...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $443.6M | |||
| Open | High | Low | Value | Volume |
| 31.5¢ | 31.8¢ | 30.3¢ | $1.189M | 3.864M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 78803 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 1155 | 1 |
View Market Depth
| Last trade - 16.10pm 17/10/2024 (20 minute delay) ? |
| IMM (ASX) Chart |